carbamazepine has been researched along with Triple Negative Breast Neoplasms in 1 studies
Carbamazepine: A dibenzazepine that acts as a sodium channel blocker. It is used as an anticonvulsant for the treatment of grand mal and psychomotor or focal SEIZURES. It may also be used in the management of BIPOLAR DISORDER, and has analgesic properties.
carbamazepine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine carrying a carbamoyl substituent at the azepine nitrogen, used as an anticonvulsant.
Triple Negative Breast Neoplasms: Breast neoplasms that do not express ESTROGEN RECEPTORS; PROGESTERONE RECEPTORS; and do not overexpress the NEU RECEPTOR/HER-2 PROTO-ONCOGENE PROTEIN.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ling, T | 1 |
| Tran, M | 1 |
| González, MA | 1 |
| Gautam, LN | 1 |
| Connelly, M | 1 |
| Wood, RK | 1 |
| Fatima, I | 1 |
| Miranda-Carboni, G | 1 |
| Rivas, F | 1 |
1 other study available for carbamazepine and Triple Negative Breast Neoplasms
| Article | Year |
|---|---|
(+)-Dehydroabietylamine derivatives target triple-negative breast cancer.
Topics: Abietanes; Antineoplastic Agents, Phytogenic; Apoptosis; Biological Products; Cell Line, Tumor; Cell | 2015 |